Goodwill and Intangible Assets (Notes)

12 Months Ended

Dec. 31, 2013

Goodwill and Intangible Assets Disclosure [Text Block]

Goodwill and Intangible Assets

The Company performed the impairment tests using quantitative assessments as of October 1, 2013. With respect to goodwill, the estimated fair values substantially exceeded the carrying amounts for all reporting units. Therefore, there was no goodwill impairment in 2013. Furthermore, the fair values of each indefinite-lived intangible asset exceeded its carrying amount. Therefore, there was no impairment of indefinite-lived intangible assets in 2013.

Goodwill

The following table represents the changes in goodwill:



	December 31,
	2013			2012
Beginning balance	$	398,941		$	288,770
Foreign currency translation adjustments and other	(344		)	408
Goodwill acquired during the year	308			109,763
Ending balance	$	398,905		$	398,941

Intangible Assets

The Company recorded an impairment loss of $3,070 during 2012 resulting in the elimination of in-process research & development ("IPR&D") indefinite-lived intangible assets related to a prior BioMedical segment acquisition. Higher forecasted costs and project delays represented impairment indicators requiring the Company to re-evaluate the fair value of the IPR&D indefinite-lived intangible assets. The Company conducted an impairment test based on the multi-period excess earnings valuation method which determines fair value based on the present value of the prospective net cash flow attributable to the intangible asset (Level 3 in the fair value hierarchy). The Company determined that the fair value of the IPR&D indefinite-lived intangible assets was zero and impaired the intangible assets by a value equal to their carrying amount.

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill)⁽¹⁾:



	Weighted-average Estimated Useful Life	December 31, 2013					December 31, 2012
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization			Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Unpatented technology	16.0 years	$	43,133	$	(11,776	)	$	45,078	$	(11,286	)
Patents	11.0 years	7,904		(5,397		)	9,880		(6,664		)
Product names	9.0 years	9,244		(4,525		)	9,068		(2,712		)
Customer relations	13.0 years	159,143		(73,460		)	158,005		(59,668		)
Total finite-lived intangible assets	13.6 years	$	219,424	$	(95,158	)	$	222,031	$	(80,330	)
Indefinite-lived intangible assets:
Trademarks and trade names		$	47,876				$	47,762

_______________


⁽¹⁾	Amounts include the impact of foreign currency translation. Fully amortized amounts are written off.

Amortization expense for intangible assets subject to amortization was $19,230, $14,792 and $13,376 for the years ended December 31, 2013, 2012 and 2011, respectively. The Company estimates amortization expense to be recognized during the next five years as follows:



For the Year Ending December 31,
2014	$	17,800
2015	16,200
2016	14,300
2017	13,400
2018	12,700

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details